We conduct scientific reviews and provide information based on regulatory science to ensure the quality, efficacy, and safety of cell-based therapeutic products used in regenerative and cellular medicine.
Our research division is dedicated to establishing a scientific foundation for evaluating the quality, efficacy, and safety of human- and animal-derived cell-based products, with the aim of promoting the rapid commercialization of effective and safe cell-based products. The division comprises four sections, each responsible for tasks aligned with its specific area of expertise.
We work on assessment methods for quality and safety, scientific frameworks for evaluation, and the organization of standards and concepts related to regenerative medical products.
We aim to deepen knowledge on the quality and safety of regenerative medical products and communicate it clearly to society, bridging research, healthcare, and the public.
Organization & Members, Achievements, and Information / Materials are available on dedicated pages.
This page presents the organizational structure headed by the director and the members belonging to each unit.
Go to Members PagePublications, conference presentations, and reports are organized by year and category.
Go to AchievementsApproval information, clinical studies, trials, and reference materials are presented in table format.
Go to Information PageUpdates can be posted in a list format. This structure is also suitable for simple operation before introducing a CMS.
We have launched the official website introducing the activities and research of our division.
The latest publications and presentation records have been added to the achievements page.
The materials page has been revised to improve clarity.
You can provide address, contact details, and transportation information here.
1-2-3 Example Town,
Example City, Example Prefecture 000-0000
Inside Example University / Research Center
TEL: 00-0000-0000
E-mail: example@example.ac.jp
Add directions such as walking time from the nearest station or bus access.